Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 300
Avg Vol 476
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 87%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Relief Therapeutics Holding SA, a biopharmaceutical company, engages in identification, development, and commercialization of novel, patent protected products for the treatment of dermatological, metabolic, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for nausea and vomiting associated with radiotherapy-induced, chemotherapy, and postoperative sequels; ACER-001, a sodium phenylbutyrate for the treatment of urea cyc...

Industry: Biotechnology
Sector: Healthcare
Address:
Avenue de Secheron 15, Geneva, Switzerland
Latest News on RLFTY
No data available.